Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Visuomotor expertise in volleyball: saccadic latency and absolute alpha power.

Frontiers in psychology·2026
Same author

Editorial: Current pharmacological challenges of Treatment-Resistant Depression.

Pharmacological research·2026
Same author

From the Scientific Underground to the Height of Recognition: The 40th Anniversary of Rita Levi-Montalcini's Nobel Prize and the Promising Horizon in Psychiatry.

Neurochemical research·2026
Same author

Kenneth Bancroft Clark and the moral arc of psychological science: Reflections 20 years after his passing.

Journal of the history of the neurosciences·2026
Same author

Giftedness: A Critical Analysis of Theories and Identification Methods in Light of Contemporary Neuroscience.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience·2026
Same author

Bridging Local Realities and Global Science: Psychiatric Education at 35 Years of Brazil's Sistema Único de Saúde.

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)·2026

Related Experiment Video

Updated: May 26, 2026

Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI
14:55

Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI

Published on: April 18, 2011

Bromazepam impairs motor response: an ERSP study.

Julio G Silva1, Oscar Arias-Carrion, Flavia Paes

  • 1Physical Therapy Department, Federal University of Rio de Janeiro (IPUB/UFRJ), Brazil.

CNS & Neurological Disorders Drug Targets
|January 11, 2012
PubMed
Summary

Bromazepam significantly altered brain activity in motor areas during a visuomotor task. This benzodiazepine derivative affected alpha and beta bands, impacting sensorimotor processing in the left primary motor cortex.

More Related Videos

Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats
09:12

Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats

Published on: March 17, 2019

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

Related Experiment Videos

Last Updated: May 26, 2026

Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI
14:55

Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI

Published on: April 18, 2011

Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats
09:12

Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats

Published on: March 17, 2019

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cognitive Science

Background:

  • Benzodiazepines, like bromazepam, are widely used for their anxiolytic and sedative effects.
  • Understanding the precise neural mechanisms of benzodiazepines, particularly their impact on sensorimotor processing, remains an active area of research.
  • Event-related spectral perturbation (ERSP) is a valuable technique for analyzing brain oscillations in response to specific events.

Purpose of the Study:

  • To investigate the acute modulatory effects of bromazepam on alpha and beta frequency bands (8-35Hz) in primary motor areas (M1).
  • To examine how bromazepam influences neural activity during a visuomotor task requiring rapid visuomotor coordination.
  • To utilize electroencephalographic (EEG) activity and ERSP to detect changes in brain dynamics.

Main Methods:

  • A cross-over, double-blind study design involving ten healthy subjects.
  • Subjects performed a rapid visuomotor task (identifying and catching a horizontally launched ball).
  • Electroencephalographic (EEG) activity was recorded and analyzed using event-related spectral perturbation (ERSP) to compare bromazepam and placebo conditions.

Main Results:

  • Statistically significant differences in brain activity were observed between bromazepam and placebo conditions.
  • Specifically, alterations were noted at 13 Hz in the time window of 2920 ms (electrodes C3 and Cz) and at 18 Hz in the time window of 2000 ms (electrode C3).
  • These findings indicate bromazepam's acute effects on information processing within the left primary motor cortex (M1).

Conclusions:

  • Acute administration of bromazepam induces measurable changes in electro-cortical activity within the sensorimotor cortex.
  • The observed effects, particularly in the alpha and beta bands, suggest bromazepam modulates neural processes related to visuomotor control.
  • This study highlights the utility of ERSP in understanding the neurophysiological impact of benzodiazepines and invites further research correlating brain activity with psychometric measures.